TLR4 and colitis: BC showed the potential to modulate the immunological response as well as the severity of the intestinal inflammatory reaction modulating Toll-Like Receptor 4 and cytokine expression, reducing body weight loss and histological score, balancing the microbiota and finally decreasing the clinical signs of colitis in mice [12].